Injectable Drug Demonstrates Efficacy with Reduced Dosing Schedule
An injectable treatment for relapsing-remitting MS (RRMS) designed to significantly reduce the dosing schedule typical of standard interferon drugs has…
MS VIEWS AND NEWS PROVIDES EDUCATIONAL INFORMATION TO THE GLOBAL MS COMMUNITY
TO SEE WHAT MS VIEWS AND NEWS PROVIDES, LOCALLY, NATIONALLY AND INTERNATIONALLY, PLEASE CLICK THIS LINK TO OPEN OUR FLYER:…
Stuart Schlossman
A Free MS Seminar in Spanish on SYMPTOM MANAGEMENT – May 23rd at 6pm
MS Views and News Invites you to this Multiple Sclerosis Educational Program SYMPTOM MANAGEMENT – MANEJO DE SINTOMAS FUTURE…
Stuart Schlossman
Thursday – April 26th at 8:30PM ET – Listen with an MS Patient who seems to have had a successful Stem Cell Transplant
This Thursday – April 26th at 8:30pm ET Listen to Stuart and Deanne of StuMS Radio and Multiple Sclerosis Unplugged,…
Stuart Schlossman
Experimental Pill for Multiple Sclerosis Shows Promise
By Steven Reinberg HealthDay Reporter File Under: Multiple Sclerosis | Neurology MONDAY, April 16 (HealthDay News) — An experimental pill reduced the number…
Stuart Schlossman
Happy New Year 2012
As 2011 comes to a close, I and the staff of MS Views and News / Stu’s Views and MS…
Stuart Schlossman
Overcoming Depression
It may be the most misunderstood illness of all, but those who experience it agree on one thing — clinical…
Stuart Schlossman
Bayer’s Betaferon Extends Multiple Sclerosis Patients’ Lives, Study Finds
By Naomi Kresge – Oct 15, 2010 Bayer AG’s betaferon multiple sclerosis treatment helped patients live longer when taken soon after the onset…
Stuart Schlossman
AMPYRA NEWS
AMPYRA NEWS For more information about AMPYRA, including patient assistance and co-pay programs, healthcare professionals and people with MS can…
Stuart Schlossman
Use “Stu’s Views & M.S. News” to learn from the web too
When using the Blog Search rectangular box found on this blog, after entering a keyword or phrase, or initials of…
Stuart Schlossman
